Orisild (Sildenafil)

Sildenafil selectively blocks phosphodiesterase type 5, an enzyme that degrades cyclic GMP. By preserving cGMP levels, it promotes smooth‑muscle relaxation in the corpus cavernosum and pulmonary vessels, enhancing blood flow that underlies its therapeutic effects.

The appropriate dose of Orisild is determined by the prescribing clinician based on the patient’s condition, response, and any concomitant medications. Dosage may vary, and patients should follow the specific instructions provided by their healthcare professional.

Sildenafil is not recommended for use during pregnancy or while breastfeeding unless a qualified healthcare provider determines that the potential benefits outweigh the risks. Women who are pregnant, planning pregnancy, or nursing should discuss alternatives with their clinician.

To order Orisild, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Orisild (sildenafil) shares the same mechanism as other PDE5 inhibitors such as tadalafil and vardenafil. Compared with longer‑acting agents, sildenafil typically has a shorter duration of action, which may be preferred for on‑demand use. Efficacy and safety profiles are broadly comparable, with individual tolerability influencing choice.

Orisild tablets should be stored at room temperature, below 25 °C, in the original packaging to protect them from moisture and excessive heat. Keep the container tightly closed and out of reach of children.

Orisild is taken orally, usually with a glass of water. The tablet should be swallowed whole and not crushed or chewed. It can be taken with or without food, but a high‑fat meal may delay its onset of action.

Serious adverse events include priapism (a prolonged erection lasting more than four hours), sudden loss of vision, sudden hearing loss, severe hypotension, and allergic reactions such as anaphylaxis. Patients experiencing any of these should seek immediate medical attention.

Orisild should be avoided by individuals taking nitrates, those with severe cardiovascular disease that precludes sexual activity, patients with a known hypersensitivity to sildenafil, and men with certain retinal disorders such as retinitis pigmentosa. Contraindications should be confirmed by a healthcare professional.